What is USpharma?
USpharma Ltd is recognized as a leading pharmaceutical manufacturer, dedicated to producing high-quality formulations for worldwide distribution. The company operates WHO-GMP certified facilities, demonstrating a commitment to stringent quality standards. Its specialization encompasses a wide range of pharmaceutical products, including tablets, capsules, and injectables, catering to diverse healthcare needs. The company's focus on quality and broad product portfolio positions it as a key player in the pharmaceutical sector.
How much funding has USpharma raised?
USpharma has raised a total of $2M across 2 funding rounds:
Debt
$1M
Debt
$1M
Debt (2020): $1M with participation from PPP
Debt (2021): $1M led by PPP
Key Investors in USpharma
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for USpharma?
The recent enterprise-level funding for USpharma signals a phase of significant growth and strategic expansion. This capital infusion is likely to bolster the company's research and development initiatives, enhance its manufacturing capabilities, and potentially facilitate entry into new global markets or strengthen its presence in existing ones. The company's trajectory suggests a focus on scaling operations and solidifying its market leadership through continued innovation and quality assurance in its pharmaceutical offerings.
See full USpharma company page
